Target intelligence / Profile preview

novel transcript, antisense to HEXB (ENSG00000306131)

Target
ENSG00000306131
Molecular classification
Non-coding RNA, Natural antisense transcript (NAT), Not an enzyme, receptor, transporter, or protein of established therapeutic targeting.
01

Overview

This entry refers to a naturally occurring RNA transcript overlapping the HEXB gene in an antisense orientation. Antisense transcripts can regulate the expression of their sense gene through mechanisms that affect mRNA stability, processing, and chromatin state near the promoter region. Such transcripts are widespread but are not considered classical therapeutic targets like enzymes or receptors. There are no established aliases, molecular families, or clinical roles specifically attributed to this particular transcript. There is no evidence for misspelling, but the entry is incomplete for therapeutic targeting purposes, as it refers to a non-coding RNA and not a protein commonly targeted in pharmacology.

Other names
novel transcript, antisense to HEXB
02

Mechanism of action

Gene expression regulation: Antisense transcription may modulate sense transcript stability, processing, and chromatin modifications affecting HEXB expression. No known drug mechanisms.

03

Biological functions

Regulation of gene expression by antisense transcription, typically by modulation of complementary HEXB mRNA processing, stability, and transcription dynamicsMay influence chromatin architecture and epigenetic marks in the region of the HEXB gene
04

Disease associations

No direct causal or therapeutic disease associations reported for this specific transcript.Indirect relevance may exist through regulatory effects on HEXB, whose dysfunction is associated with Sandhoff disease, a lysosomal storage disorder.However, evidence for the antisense transcript’s direct involvement in disease is lacking.

Beyond the preview

Go deeper on novel transcript, antisense to HEXB (ENSG00000306131).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to HEXB (ENSG00000306131).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call